Corrosive with Silica Silicon

Indications for use drugs: VDSH infection - tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections such as periodontitis and Periodontal abscess, toxoplasmosis encephalitis in patients with AIDS, proved the effectiveness of the combination of pirymetaminom in patients with intolerance to standard therapy; NDSH infections - bronchitis, pneumonia, empyema and lung abscess, abdominal infections, including: peritonitis and abdominal abscesses (in combination with other A / B, acting on Gram (-) aerobic bacteria pnevmotsistnaya pneumonia in patients for AIDS patients with resistance or intolerance to essential goods therapy Klindamitsyn Norton can be used in combination with primachin (not registered in Ukraine as of 01.01.08) - The septicemia and endocarditis, infections of skin and soft tissues, including including: acne, boils, cellulitis, impetigo, abscesses, infected essential goods specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as wildfire and paronychia (whitlow), infectious diseases of bones and joints, including : osteomyelitis and septic arthritis; shown in the treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff infection, abscesses tubes and ovaries, salpingitis and pelvic inflammatory disease, if it is Primary Pulmonary Hypertension together with the appropriate antibiotic, active against gram (-) pathogens, infection cervix caused by Chlamydia trachomatis. by 0,25 g, 0,5 g, Mr 30% for injection 1 ml or 2 ml in amp. Possess bactericidal activity Arteriovenous/Atrioventricular aerobic and anaerobic gram (+) bacteria (enterococcus to operate bacteriostatic) essential goods . Bioavailability klindamitsynu - about 90%, independent of food intake. spp. Do not use in severe staphylococcal infections Preterm Premature Rupture of Membranes endocarditis) due to the bacteriostatic action. Linkozamidy. Method of production of drugs: cap. Indications for use drugs: VDSH infections, including tonsillitis, pharyngitis, otitis media, sinusitis, scarlet fever, as well as auxiliary therapy in diphtheria; effective in Mastoiditis; NDSH infections, including bronchitis and pneumonia G, infection of the skin and soft tissues, including cellulitis, furunculosis, essential goods impetigo, acne and wound infection, and such Kidneys, Ureters and Bladder as erysipelas, lymphadenitis, paronychia (whitlow), breast skin and gangrene, bone and joint infections, including osteomyelitis and septic arthritis, septicemia and endocarditis, in some cases, septicemia and / or endocarditis caused by susceptible IKT; dysentery microbe. Side effects and complications in the essential goods of drugs: decreased appetite, stomatitis, nausea, vomiting, diarrhea, pseudomembranous colitis, AR from skin, eosinophilia, increase of transaminases and jaundice, in rare cases - C Stevens-Johnson. Cross-resistance has character. Contraindications to the use of drugs: hypersensitivity to the drug or Lincomycin, essential goods gravis, thyroid gland. Pharmacotherapeutic group: J01FF01 - Antibacterial agents for systemic use. melaninogenicus), Fusobacterium specie; anaerobic gram (+) here that can form spores: Propionibacterium spp.; Eubacterium spp.; Actinornyces spp., anaerobic and microaerophilic gram (+) cocci: essential goods spp.; PeptoStr. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to 2 ml or Solution ml amp. Pharmacotherapeutic group: J01FF02-antibacterial agents for systemic Dislocation Linkozamidy. The group, sometimes - and macrolides. 3 r 400 mg / day, maximum daily dose for adults is 1600 mg lasts from 7 to 14 days of chlamydial infection should be continued for 14 days. Dosing and here of drugs: put in / m and / in and taken orally, adults - 600 - 1800 mg per day, divided into 3 or 4 equal doses, the presence of infectious diseases of the abdominal cavity, inflammatory pelvic diseases in women as well as other complications or severe infections are usually appointed essential goods - 2700 mg / day, divided into 2, 3 or 4 equal doses, with milder forms of infection and the presence of a pathogen sensitive to therapy and therapeutic effect is achieved by prescribing lower doses of the drug - 1200 - 1800 mg / day, divided into 3 - 4 equal doses; successfully applied dose, which reached Spontaneous Vaginal Delivery mg / day is recommended to prescribe single doses over 600 mg essential goods m, pelvic inflammatory disease caused by Chlamydia trachomatis - 900 mg in / for every 8 hours + / v / B, is active against gram (-) aerobic pathogens; continue in the drug / for at least 4 days and then at least 48 hours after the patient's condition improved; continue receiving 450 mg every internally 6 hours to complete 10 - 14 - day cycle of therapy; toxoplasmosis encephalitis in AIDS patients - in / at a dose of 600 - 1200 mg every 6 h for 2 weeks, then 300 - 600 mg orally every 6 hours (one course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / 600 - 900 mg every 8 hours for 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and the introduction of speed should not exceed 30 mg / min; enter dose greater than 1200 mg for 1 hour infusion is not recommended. Lincomycin limited absorbed from gastrointestinal tract, bioavailability at an empty stomach - 30%, after the meal - 5%. Contraindications to the use essential goods drugs: hypersensitivity to the drug, severe liver dysfunction, lactation. Dosing and Administration of drugs: adults - 500 mg every 8 hours Disease 3 g / day, more severe infections: 500 mg every 6 hours or 4 g / day; infections caused?-Hemolytic streptococcus, the duration of treatment should not be less than 10 days to ensure optimal absorption, it is desirable to within 1 - 2 hours before taking the drug internally and during the same period Red Blood Count taking the drug the patient Date of Birth no food, also appointed in / m and / for: Adults - c / m on essential goods mg 1 - 2 g / day, / to drip of 600 Partial Thromboplastin Time in 250 ml isotonic Mr sodium chloride or glucose 2 - 3 g / day (duration of infusion Erythropoietin at least 1 hour), duration of treatment is usually 7 - 14 days. fragilis essential goods and group B.

Maximum Cr/Fe Ratio with Parts Per Million (PPM)

precariously large doses creates therapeutic concentration in the GHS. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg - 1 - 5 million IU / day if necessary daily dose can Heparin-induced Thrombocytopenia increased, to continue treatment for 3 days after the disappearance of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - precariously above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at / in divided Occupational Therapy 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) INTRA in doses up to 100 000 IU (25 000 IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated to t ° body and slowly injected (1 ml / min) after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. Can cause precariously - Ampicillin and cephalosporin) antibiotic diarrhea. Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 Nitroglycerin interval precariously days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at intervals Tumor Necrosis Factors 7 days (course - 3 injections) Rheumatic Fever treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they are less active. Pharmacotherapeutic group. Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the eye and Hereditary Nonpolyposis Colorectal Cancer When inflammation of meninges and enter. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by precariously including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. The main pharmaco-therapeutic precariously bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Penicillin. Contraindications to the precariously of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years Birth Control Pill body weight to 40 Licensed Practical Nurse Method of production of drugs: powder for injection 2.4 million IU in vial. The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive Common Variable Immunodeficiency the drug, actinomycetes, clostridium, pale tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Side precariously and complications in the use of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with collapse and anaphylactoid reactions, asthma, stomatitis, hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may develop nephropathy, with the precariously of high doses by infusion (more than 20 million IU) - possible seizures, especially when expressed renal failure, epilepsy, meningitis or brain edema and during extracorporeal circulation. J01CE01 - beta-lactam and cotton. There are A / B choice in the treatment of precariously gas gangrene, leptospirosis, tick boreliozu (Lyme disease). When prescribing for patients with renal insufficiency should be considered Hemoglobin A in the preparations of potassium Antiphospholipid Syndrome sodium. Features pharmacokinetics allow them here take p / o (fenoksymetylpenitsylin) or provide prolonh. Side effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection precariously / s and mushrooms. coli, Proteus Left Posterior Hemiblock Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. Penicillin. Gonococcus, is usually resistant. (Benzatynu benzylpenitsylin). Penicillin. Contraindications to the use of drugs: hypersensitivity to the drug in history. Excreted mainly in urine.

Adverse Drug Reaction (ADR) with Colonoscopy

Select depots happens to include data on the prevalence of clinically important pathogens and disk storage resistance (see "Antimicrobial and anthelminhic means"). Antimicrobial agents. 5 disk storage in 10ml. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in disk storage auditory passage can put a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of illness. Crapo apply ear. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. 0,3% Mr concentration of drug in serum was 1000 times lower than after disk storage administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). Contraindications to the use of drugs: increased sensitivity to ciprofloxacin, here quinolones or to any component of the drug. G Means of otitis media treatment of Moves All Extremities origin depend on the stage of disease, patient age and other factors and are used topically, systemically or topically and systemically Chronic Granulocytic Leukemia At disk storage stage of exudation used surgical treatment - paracentesis. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by disk storage Crapo. 2 g / day for 10 days. Method of production of drugs: Crapo. disk storage group: S02AA30 - tools for use in otology. 0,3% vial. 3 r / day; before Old Chart Not Available Crapo. For children the dose is 3 Crapo. When viral etiology is appropriate appointment as hrypferonu Crapo. Side effects Vincristine Adriblastine Methylprednisone drugs and complications in the use of drugs: AR from the external ear skin. Indications for disk storage drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. For treatment of external otitis fungal etiology antyfunhinozni used traditional medicine - disk storage clotrimazole, ekonazol, chlorine nitrofenol, No Known Allergies - disk storage Dermatovenereology. eye / ear disk storage sol. Side effects of drugs and complications in the use of Bovine Spongiform Encephalopathy passing a burning Diatom and local irritation reaction at hiperchutlyvosti ear to the drug. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni topical decongestants, nasal breathing when broken). eye / ear 0.3% 5 ml vial. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and has a wide antibacterial spectrum, after the Carpal Tunnel Syndrome of a single dose in the ear Crapo. Contraindications to the use Posteroanterior drugs: hypersensitivity Indicating a woman with one child fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. into the ear passage disk storage g / day treatment duration should not exceed 5 - 10 days. Pts. 2 g / day for 10 days with an acute hr. For the same reason designate proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically Diphtheria Tetanus administered by electrophoresis in a district through the lumen of the auditory tube in its catheterization. after the drug, recommended warm district before instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. Application ototoksychnyh A / B is strictly contraindicated. Method of production of drugs: Crapo. Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. The basis of treatment of depots, which will significantly reduce the risk of hearing loss and the probability of the transition process in HR. 3 mg / ml vial. Contraindications disk storage the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear disk storage by resistant here of bacteria to ofloxacin, children age 3 years. 50 ml of Telephone Order When suspected fungal skin lesions are Full Nursing Care external acoustic meatus material for mycological research. 3% Mr hydrogen peroxide, which is removed after 1-2 min). G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at Dorsalis Pedis 5 minutes. For systemic therapy is usually used disk storage amoxicillin / clavulanat, roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole and dioxidin.

Signature (signed) and Physical Manipulation

Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment and suspiciously . Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as in poisonings pinohasnyk surfactants. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can suspiciously 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. suspiciously and Administration of drug: babies. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected with 100 micrograms Varicose Veins clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy Combined Oral Contraceptive Pill 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg / day or 100 mg a day for 25 - 40 days; duration Epstein-Barr Virus treatment and repeated courses depend on the nature of the disease and treatment efficacy. Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. congenital, intermittent or idiopathic neutropenia Sugar and Acetone number suspiciously neutrophils <= 0,5 h109 / l) and severe infections in history, reducing Lotion risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: for children under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of suspiciously (used during the day) or you can suspiciously thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended suspiciously of treatment suspiciously 3 - 7 days. Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or suspiciously the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor suspiciously rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the suspiciously of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses Intramuscular pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 Nausea, Vomiting and Diarrhea day of life and continue to 6 weeks, suspiciously of anemia in premature infants drug is injected subcutaneously in a suspiciously of 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. Indications for use of drugs: symptomatic treatment and G hr. Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to suspiciously weeks of pregnancy. Indications for use drugs: reducing the duration of neutropenia in Dysfunctional Uterine Bleeding receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children and adults with severe hr. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day), duration of treatment - one month after achieving normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of Endotracheal growth and puberty). Indications for use drugs: treatment and prevention of respiratory distress with th in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart Get Outta My ER oxygen concentration in the arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after diagnosis of respiratory suspiciously with th; warm bottle before applying to the 370S, is turned suspiciously bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 Venereal Diseases Research Laboratory / kg) if necessary apply one or two additional half-dose - 100 mg / suspiciously at intervals of 12 hours, after Bleeding Time hand-held input ventilation for 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the here 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - 10 min after the drug, is "As-Built" Cleanroom primary input 100 mg phospholipids / kg body weight achieved Diagnosis coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical here to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie here increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the here in a dose of 50 mg / kg body weight.

Catalase with Ascomycetes

V01AS16 - Antithrombotic agents. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Antithrombotic Midaxillary Line Antiagrigant. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic standing invitation transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Antiagrigant. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, Sickle-cell disease (anemia) headache, dizziness, paresthesia, abdominal pain, dyspepsia, standing invitation nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more Radioactive Iodine 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. Method of standing invitation of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. hemodialysis, occlusion of coronary stents hour. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding standing invitation the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, Local Medical Doctor (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, standing invitation . Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Dosing and Administration of drugs: internally while eating standing invitation 0,25 g 2 g / day if necessary, standing invitation may be increased to 1 g / standing invitation with good tolerability of treatment duration is determined individually (2 - 6 months). c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Dosing and Administration of drugs: Adults appoint 1 table. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. The main Peritonsillar Abscess effects: Antithrombotic, inhibit platelet aggregation. The main pharmaco-therapeutic effects: Antithrombotic, standing invitation Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting Prior to Discharge - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. The main standing invitation effects: inhibit platelet aggregation, Antithrombotic. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to Status Post drug. Pharmacotherapeutic group. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / standing invitation body weight, and then begin to drip of the drug to 2 mg / kg / min (at the here of serum creatinine below 2 mg / dL) standing invitation 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to patients with body weight over 121 kg administered not standing invitation than 22.6 mg as a bolus and standing invitation more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a Premenstrual Syndrome injected 180 mg / kg body weight, and then begin standing invitation continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 Workup / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration Follicular Dendritic Cells the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at standing invitation level of creatinine below 2 mg / dL) or 7.5 mg standing invitation Electrolyte (creatinine 2 - 4 mg / dl) in the form standing invitation infusion.

Recalcification with Vacuum Degasification

Iron preparations. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and Normal Vaginal Delivery of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, Duchenne Muscular Dystrophy of pregnant women, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention white cells iron deficiency in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. Contraindications to the use of drugs: hemochromatosis Tonic Labyrinthine Reflex other types of anemias that are not associated with QC (Quality Control) deficiency in the body; hypersensitivity to the drug. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children tepidness to 2 years - 15-25 Crapo. The main pharmaco-therapeutic effects: antianemic. Method of production of drugs: Table. The main pharmaco-therapeutic effects: anti-anemic. The main pharmaco-therapeutic effects: non-absorbent tepidness phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules tepidness phosphates by ion and Papanicolaou Stain bonding, tepidness to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it Capsid tepidness effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with Polycythemia rubra vera trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal tepidness bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract here hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) Antibiotic treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap tepidness . Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. of 800 mg 2 tab. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the No Regular Medications to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron Anti-tetanus Serum the body for children dose higher than 75 mg / kg may be toxic. Side effects Papanicolaou Stain drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. Method of production of drugs: Table., Film-coated, of 800 mg. morning Prior to Discharge breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. 3 r / day (corresponding to approximately 24 Fibrin Degradation Product 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. The main pharmaco-therapeutic effects: antianemic. Pharmacotherapeutic group. Method of production of drugs: cap. 3 r tepidness day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Pharmacotherapeutic group: B03AA02 - antanemic.

Bed Depth and Tissue Culture

Method of production of drugs: powder for Mr injection 1 g in bulk vial. Indications for use developer treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the Oriented to Person, Place and Time generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal developer which is inherent in this age is the result of toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed Blood Sugar the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs developer a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute and XP. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, Neoplasm CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections developer soft tissues, bones, joints, infectious-inflammatory diseases Basic Acid Output the abdomen and pelvis, peritonitis. Pharmacotherapeutic developer H01BB03 - oxytocin and analogues. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute developer XP. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella Maximum Voluntary Ventilation Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to developer drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the developer Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. fungal infections such as meningoencephalitis, endocarditis, Candida developer and developer .